BACKGROUND AND PURPOSE: Src homology 3-domain growth factor receptor-bound 2-like endophilin interacting protein 1 (SGIP1) interacts with cannabinoid CB1 receptors. SGIP1 is abundantly and principally expressed within the nervous system. SGIP1 and CB1 receptors co-localize in axons and presynaptic boutons. SGIP1 interferes with the internalization of activated CB1 receptors in transfected heterologous cells. Consequently, the transient association of CB1 receptors with β-arrestin2 is enhanced and prolonged, and CB1 receptor-mediated ERK1/2 signalling is decreased. Because of these actions, SGIP1 may modulate affect, anxiety, pain processing, and other physiological processes controlled by the endocannabinoid system (ECS). EXPERIMENTAL APPROACH: Using a battery of behavioural tests, we investigated the consequences of SGIP1 deletion in tasks regulated by the ECS in SGIP1 constitutive knockout (SGIP1-/- ) mice. KEY RESULTS: In SGIP1-/- mice, sensorimotor gating, exploratory levels, and working memory are unaltered. SGIP1-/- mice have decreased anxiety-like behaviours. Fear extinction to tone is facilitated in SGIP1-/- females. Several cannabinoid tetrad behaviours are altered in the absence of SGIP1. SGIP1-/- males exhibit abnormal behaviours on Δ9 -tetrahydrocannabinol withdrawal. SGIP1 deletion also reduces acute nociception, and SGIP1-/- mice are more sensitive to analgesics. CONCLUSION AND IMPLICATIONS: SGIP1 was detected as a novel protein associated with CB1 receptors, and profoundly modified CB1 receptor signalling. Genetic deletion of SGIP1 particularly affected behavioural tests of mood-related assessment and the cannabinoid tetrad. SGIP1-/- mice exhibit decreased nociception and augmented responses to CB1 receptor agonists and morphine. These in vivo findings suggest that SGIP1 is a novel modulator of CB1 receptor-mediated behaviour.

Department of Molecular Pharmacology Institute of Molecular Genetics of the Czech Academy of Sciences Prague 4 Czech Republic

Department of Psychological and Brain Sciences Gill Center for Molecular Bioscience Indiana University Bloomington Indiana USA

The Czech Center for Phenogenomics Institute of Molecular Genetics of the Czech Academy of Sciences Vestec Czech Republic

Zobrazit více v PubMed

Alexander, S. P. H. , Christopoulos, A. , Davenport, A. P. , Kelly, E. , Mathie, A. , Peters, J. A. , Veale, E. L. , Armstrong, J. F. , Faccenda, E. , Harding, S. D. , Pawson, A. J. , Sharman, J. L. , Southan, C. , Davies, J. A. , & Collaborators C . (2019). The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors. British Journal of Pharmacology, 176(Suppl 1), S21–S141. PubMed PMC

Alexander, S. P. H. , Fabbro, D. , Kelly, E. , Mathie, A. , Peters, J. A. , Veale, E. L. , Armstrong, J. F. , Faccenda, E. , Harding, S. D. , Pawson, A. J. , Sharman, J. L. , Southan, C. , Davies, J. A. , & CGTP Collaborators . (2019). The Concise Guide to PHARMACOLOGY 2019/20: Enzymes. British Journal of Pharmacology, 176, S297–S396. 10.1111/bph.14752 PubMed DOI PMC

Bortolato, M. , Mangieri, R. A. , Fu, J. , Kim, J. H. , Arguello, O. , Duranti, A. , Tontini, A. , Mor, M. , Tarzia, G. , & Piomelli, D. (2007). Antidepressant‐like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biological Psychiatry, 62, 1103–1110. 10.1016/j.biopsych.2006.12.001 PubMed DOI

Bourin, M. , & Hascoet, M. (2003). The mouse light/dark box test. European Journal of Pharmacology, 463, 55–65. 10.1016/S0014-2999(03)01274-3 PubMed DOI

Breivogel, C. S. , Lambert, J. M. , Gerfin, S. , Huffman, J. W. , & Razdan, R. K. (2008). Sensitivity to Δ9‐tetrahydrocannabinol is selectively enhanced in beta‐arrestin2−/− mice. Behavioural Pharmacology, 19, 298–307. 10.1097/FBP.0b013e328308f1e6 PubMed DOI PMC

Canals, M. , & Milligan, G. (2008). Constitutive activity of the cannabinoid CB1 receptor regulates the function of co‐expressed Mu opioid receptors. The Journal of Biological Chemistry, 283, 11424–11434. 10.1074/jbc.M710300200 PubMed DOI

Choleris, E. , Thomas, A. W. , Kavaliers, M. , & Prato, F. S. (2001). A detailed ethological analysis of the mouse open field test: Effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neuroscience and Biobehavioral Reviews, 25, 235–260. 10.1016/S0149-7634(01)00011-2 PubMed DOI

Chwedorowicz, R. , Raszewski, G. , Kapka‐Skrzypczak, L. , Sawicki, K. , & Studzinski, T. (2016). Event‐related potentials (ERP) and SGIP1 gene polymorphisms in alcoholics: Relation to family history of alcoholism and drug usage. Annals of Agricultural and Environmental Medicine, 23, 618–624. 10.5604/12321966.1226856 PubMed DOI

Compton, D. R. , Aceto, M. D. , Lowe, J. , & Martin, B. R. (1996). In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of delta 9‐tetrahydrocannabinol‐induced responses and apparent agonist activity. The Journal of Pharmacology and Experimental Therapeutics, 277, 586–594. PubMed

Cook, S. A. , Lowe, J. A. , & Martin, B. R. (1998). CB1 receptor antagonist precipitates withdrawal in mice exposed to Δ9‐tetrahydrocannabinol. The Journal of Pharmacology and Experimental Therapeutics, 285, 1150–1156. PubMed

Costa, B. , & Colleoni, M. (1999). SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists. Zhongguo Yao Li Xue Bao, 20, 1103–1108. PubMed

Coutts, A. A. , Anavi‐Goffer, S. , Ross, R. A. , MacEwan, D. J. , Mackie, K. , Pertwee, R. G. , & Irving, A. J. (2001). Agonist‐induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. Journal of Neuroscience, 21, 2425–2433. 10.1523/JNEUROSCI.21-07-02425.2001 PubMed DOI PMC

Crawley, J. , & Goodwin, F. K. (1980). Preliminary‐report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacology Biochemistry and Behavior, 13, 167–170. 10.1016/0091-3057(80)90067-2 PubMed DOI

Cummings, N. , Shields, K. A. , Curran, J. E. , Bozaoglu, K. , Trevaskis, J. , Gluschenko, K. , Cai, G. , Comuzzie, A. G. , Dyer, T. D. , Walder, K. R. , Zimmet, P. , Collier, G. R. , Blangero, J. , & Jowett, J. B. (2012). Genetic variation in SH3‐domain GRB2‐like (endophilin)‐interacting protein 1 has a major impact on fat mass. International Journal of Obesity, 36, 201–206. 10.1038/ijo.2011.67 PubMed DOI

Curtis, M. J. , Alexander, S. , Cirino, G. , Docherty, J. R. , George, C. H. , Giembycz, M. A. , Hoyer, D. , Insel, P. A. , Izzo, A. A. , Ji, Y. , MacEwan, D. J. , Sobey, C. G. , Stanford, S. C. , Teixeira, M. M. , Wonnacott, S. , & Ahluwalia, A. (2018). Experimental design and analysis and their reporting II: Updated and simplified guidance for authors and peer reviewers. British Journal of Pharmacology, 175, 987–993. 10.1111/bph.14153 PubMed DOI PMC

Daaka, Y. , Luttrell, L. M. , Ahn, S. , Della Rocca, G. J. , Ferguson, S. S. G. , Caron, M. G. , & Lefkowitz, R. J. (1998). Essential role for G protein‐coupled receptor endocytosis in the activation of mitogen‐activated protein kinase. Journal of Biological Chemistry, 273, 685–688. 10.1074/jbc.273.2.685 PubMed DOI

Daigle, T. L. , Kwok, M. L. , & Mackie, K. (2008). Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation‐dependent mechanism. Journal of Neurochemistry, 106, 70–82. 10.1111/j.1471-4159.2008.05336.x PubMed DOI PMC

Danandeh, A. , Vozella, V. , Lim, J. , Oveisi, F. , Ramirez, G. L. , Mears, D. , Wynn, G. , & Piomelli, D. (2018). Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma‐induced long‐term anxiety. Psychopharmacology, 235, 3211–3221. 10.1007/s00213-018-5020-7 PubMed DOI

Dergai, O. , Novokhatska, O. , Dergai, M. , Skrypkina, I. , Tsyba, L. , Moreau, J. , & Rynditch, A. (2010). Intersectin 1 forms complexes with SGIP1 and Reps1 in clathrin‐coated pits. Biochemical and Biophysical Research Communications, 402, 408–413. 10.1016/j.bbrc.2010.10.045 PubMed DOI

Dickinson, M. E. , Flenniken, A. M. , Ji, X. , Teboul, L. , Wong, M. D. , White, J. K. , Meehan, T. F. , Weninger, W. J. , Westerberg, H. , Adissu, H. , Baker, C. N. , Bower, L. , Brown, J. M. , Caddle, L. B. , Chiani, F. , Clary, D. , Cleak, J. , Daly, M. J. , Denegre, J. M. , … Murray, S. A. (2016). High‐throughput discovery of novel developmental phenotypes. Nature, 537, 508–514. 10.1038/nature19356 PubMed DOI PMC

Dudok, B. , Barna, L. , Ledri, M. , Szabo, S. I. , Szabadits, E. , Pinter, B. , Woodhams, S. G. , Henstridge, C. M. , Balla, G. Y. , Nyilas, R. , Varga, C. , Lee, S.‐H. , Matolcsi, M. , Cervenak, J. , Kacskovics, I. , Watanabe, M. , Sagheddu, C. , Melis, M. , Pistis, M. , … Katona, I. (2015). Cell‐specific STORM super‐resolution imaging reveals nanoscale organization of cannabinoid signaling. Nature Neuroscience, 18, 75–86. 10.1038/nn.3892 PubMed DOI PMC

Fattore, L. , & Fratta, W. (2010). How important are sex differences in cannabinoid action? British Journal of Pharmacology, 160, 544–548. 10.1111/j.1476-5381.2010.00776.x PubMed DOI PMC

Francis, D. L. , & Schneider, C. (1971). Jumping after naloxone precipitated withdrawal of chronic morphine in rat. British Journal of Pharmacology, 41, P424–P425. PubMed PMC

Hajkova, A. , Techlovska, S. , Dvorakova, M. , Chambers, J. N. , Kumpost, J. , Hubalkova, P. , Prezeau, L. , & Blahos, J. (2016). SGIP1 alters internalization and modulates signaling of activated cannabinoid receptor 1 in a biased manner. Neuropharmacology, 107, 201–214. 10.1016/j.neuropharm.2016.03.008 PubMed DOI

Hasanein, P. , Parviz, M. , Keshavarz, M. , & Javanmardi, K. (2007). CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception. Clinical and Experimental Pharmacology & Physiology, 34, 439–449. 10.1111/j.1440-1681.2007.04592.x PubMed DOI

Hebbali A (2020). Olsrr: Tools for Building OLS Regression Models. R package version 0.5.3. https://CRAN.R-project.org/package=olsrr

Henne, W. M. , Kent, H. M. , Ford, M. G. J. , Hegde, B. G. , Daumke, O. , Butler, P. J. G. , Mittal, R. , Langen, R. , Evans, P. R. , & McMahon, H. T. (2007). Structure and analysis of FCHo2F‐BAR domain: A dimerizing and membrane recruitment module that effects membrane curvature. Structure, 15, 839–852. 10.1016/j.str.2007.05.002 PubMed DOI

Hollopeter, G. , Lange, J. J. , Zhang, Y. , Vu, T. N. , Gu, M. Y. , Ailion, M. , Lambie, E. J. , Slaughter, B. D. , Unruh, J. R. , Florens, L. , & Jorgensen, E. M. (2014). The membrane‐associated proteins FCHo and SGIP are allosteric activators of the AP2 clathrin adaptor complex. eLife, 3, 65–78. PubMed PMC

Hsieh, C. , Brown, S. , Derleth, C. , & Mackie, K. (1999). Internalization and recycling of the CB1 cannabinoid receptor. Journal of Neurochemistry, 73, 493–501. 10.1046/j.1471-4159.1999.0730493.x PubMed DOI

Hughes, R. N. (2004). The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neuroscience and Biobehavioral Reviews, 28, 497–505. 10.1016/j.neubiorev.2004.06.006 PubMed DOI

Jenniches, I. , Ternes, S. , Albayram, O. , Otte, D. M. , Bach, K. , Bindila, L. , Michel, K. , Lutz, B. , Bilkei‐Gorzo, A. , & Zimmer, A. (2016). Anxiety, stress, and fear response in mice with reduced endocannabinoid levels. Biological Psychiatry, 79, 858–868. 10.1016/j.biopsych.2015.03.033 PubMed DOI

Jin, W. , Brown, S. , Roche, J. P. , Hsieh, C. , Celver, J. P. , Kovoor, A. , Chavkin, C. , & Mackie, K. (1999). Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. The Journal of Neuroscience, 19, 3773–3780. 10.1523/JNEUROSCI.19-10-03773.1999 PubMed DOI PMC

Kathuria, S. , Gaetani, S. , Fegley, D. , Valino, F. , Duranti, A. , Tontini, A. , Mor, M. , Tarzia, G. , La Rana, G. , Calignano, A. , Giustino, A. , Tattoli, M. , Palmery, M. , Cuomo, V. , & Piomelli, D. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nature Medicine, 9, 76–81. 10.1038/nm803 PubMed DOI

Ledent, C. , Valverde, O. , Cossu, C. , Petitet, F. , Aubert, L. F. , Beslot, F. , Böhme, G. A. , Imperato, A. , Pedrazzini, T. , Roques, B. P. , Vassart, G. , Fratta, W. , & Parmentier, M. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401–404. 10.1126/science.283.5400.401 PubMed DOI

Lein, E. S. , Hawrylycz, M. J. , Ao, N. , Ayres, M. , Bensinger, A. , Bernard, A. , Boe, A. F. , Boguski, M. S. , Brockway, K. S. , Byrnes, E. J. , Chen, L. , Chen, L. , Chen, T.‐M. , Chin, M. C. , Chong, J. , Crook, B. E. , Czaplinska, A. , Dang, C. N. , Datta, S. , … Jones, A. R. (2007). Genome‐wide atlas of gene expression in the adult mouse brain. Nature, 445, 168–176. 10.1038/nature05453 PubMed DOI

Leterrier, C. , Bonnard, D. , Carrel, D. , Rossier, J. , & Lenkei, Z. (2004). Constitutive endocytic cycle of the CB1 cannabinoid receptor. The Journal of Biological Chemistry, 279, 36013–36021. 10.1074/jbc.M403990200 PubMed DOI

Li, A. L. , Carey, L. M. , Mackie, K. , & Hohmann, A. G. (2017). Cannabinoid CB2 agonist GW405833 suppresses inflammatory and neuropathic pain through a CB1 mechanism that is independent of CB2 receptors in mice. Journal of Pharmacology and Experimental Therapeutics, 362, 296–305. 10.1124/jpet.117.241901 PubMed DOI PMC

Lilley, E. , Stanford, S. C. , Kendall, D. E. , Alexander, S. P. , Cirino, G. , Docherty, J. R. , George, C. H. , Insel, P. A. , Izzo, A. A. , Ji, Y. , Panettieri, R. A. , Sobey, C. G. , Stefanska, B. , Stephens, G. , Teixeira, M. , & Ahluwalia, A. (2020). ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020. British Journal of Pharmacology, 177, 3611–3616. https://doi.org/10.1111/bph.15178 PubMed DOI PMC

Lister, R. G. (1987). The use of a plus‐maze to measure anxiety in the mouse. Psychopharmacology, 92, 180–185. 10.1007/BF00177912 PubMed DOI

Lopez‐Gallardo, M. , Lopez‐Rodriguez, A. B. , Llorente‐Berzal, A. , Rotllant, D. , Mackie, K. , Armario, A. , Nadal, R. , & Viveros, M. P. (2012). Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain‐derived neurotrophic factor in a sexually dimorphic fashion. Neuroscience, 204, 90–103. 10.1016/j.neuroscience.2011.09.063 PubMed DOI PMC

Lutz, B. , Marsicano, G. , Maldonado, R. , & Hillard, C. J. (2015). The endocannabinoid system in guarding against fear, anxiety and stress. Nature Reviews. Neuroscience, 16, 705–718. 10.1038/nrn4036 PubMed DOI PMC

Marsicano, G. , Wotjak, C. T. , Azad, S. C. , Bisogno, T. , Rammes, G. , Cascio, M. G. , Hermann, H. , Tang, J. , Hofmann, C. , Zieglgänsberger, W. , Di Marzo, V. , & Lutz, B. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature, 418, 530–534. 10.1038/nature00839 PubMed DOI

Martin, B. R. , Compton, D. R. , Thomas, B. F. , Prescott, W. R. , Little, P. J. , Razdan, R. K. , Johnson, M. R. , Melvin, L. S. , Mechoulam, R. , & Ward, S. J. (1991). Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacology, Biochemistry, and Behavior, 40, 471–478. 10.1016/0091-3057(91)90349-7 PubMed DOI

Martini, L. , Thompson, D. , Kharazia, V. , & Whistler, J. L. (2010). Differential regulation of behavioral tolerance to WIN55,212‐2 by GASP1. Neuropsychopharmacology, 35, 1363–1373. 10.1038/npp.2010.6 PubMed DOI PMC

Martini, L. , Waldhoer, M. , Pusch, M. , Kharazia, V. , Fong, J. , Lee, J. H. , Freissmuth, C. , & Whistler, J. L. (2007). Ligand‐induced down‐regulation of the cannabinoid 1 receptor is mediated by the G‐protein‐coupled receptor‐associated sorting protein GASP1. FASEB Journal, 21, 802–811. 10.1096/fj.06-7132com PubMed DOI

Mascarenhas, D. C. , Gomes, K. S. , Sorregotti, T. , & Nunes‐de‐Souza, R. L. (2017). Blockade of cannabinoid CB1 receptors in the dorsal periaqueductal gray unmasks the antinociceptive effect of local injections of anandamide in mice. Frontiers in Pharmacology, 8, 695–706. 10.3389/fphar.2017.00695 PubMed DOI PMC

Mascia, F. , Klotz, L. , Lerch, J. , Ahmed, M. H. , Zhang, Y. , & Enz, R. (2017). CRIP1a inhibits endocytosis of G‐protein coupled receptors activated by endocannabinoids and glutamate by a common molecular mechanism. Journal of Neurochemistry, 141, 577–591. 10.1111/jnc.14021 PubMed DOI

Matsuda, S. , Matsuzawa, D. , Ishii, D. , Tomizawa, H. , Sutoh, C. , & Shimizu, E. (2015). Sex differences in fear extinction and involvements of extracellular signal‐regulated kinase (ERK). Neurobiology of Learning and Memory, 123, 117–124. 10.1016/j.nlm.2015.05.009 PubMed DOI

McDonald, N. A. , Henstridge, C. M. , Connolly, C. N. , & Irving, A. J. (2007). An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor. Molecular Pharmacology, 71, 976–984. 10.1124/mol.106.029348 PubMed DOI

Mechoulam, R. , & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology, 64, 21–47. 10.1146/annurev-psych-113011-143739 PubMed DOI

Meng, I. D. , Manning, B. H. , Martin, W. J. , & Fields, H. L. (1998). An analgesia circuit activated by cannabinoids. Nature, 395, 381–383. 10.1038/26481 PubMed DOI

Micale, V. , Di Marzo, V. , Sulcova, A. , Wotjak, C. T. , & Drago, F. (2013). Endocannabinoid system and mood disorders: Priming a target for new therapies. Pharmacology & Therapeutics, 138, 18–37. 10.1016/j.pharmthera.2012.12.002 PubMed DOI

Mikasova, L. , Groc, L. , Choquet, D. , & Manzoni, O. J. (2008). Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization. Proceedings of the National Academy of Sciences of the United States of America, 105, 18596–18601. 10.1073/pnas.0805959105 PubMed DOI PMC

Moreira, F. A. , Kaiser, N. , Monory, K. , & Lutz, B. (2008). Reduced anxiety‐like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid‐degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology, 54, 141–150. 10.1016/j.neuropharm.2007.07.005 PubMed DOI

Morena, M. , Patel, S. , Bains, J. S. , & Hill, M. N. (2016). Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology, 41, 80–102. 10.1038/npp.2015.166 PubMed DOI PMC

Morgan, D. J. , Davis, B. J. , Kearn, C. S. , Marcus, D. , Cook, A. J. , Wager‐Miller, J. , Straiker, A. , Myoga, M. H. , Karduck, J. , Leishman, E. , Sim‐Selley, L. J. , Czyzyk, T. A. , Bradshaw, H. B. , Selley, D. E. , & Mackie, K. (2014a). Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice. The Journal of Neuroscience, 34, 5152–5163. 10.1523/JNEUROSCI.3445-12.2014 PubMed DOI PMC

Morgan, D. J. , Davis, B. J. , Kearn, C. S. , Marcus, D. , Cook, A. J. , Wager‐Miller, J. , Straiker, A. , Myoga, M. H. , Karduck, J. , Leishman, E. , Sim‐Selley, L. J. , Czyzyk, T. A. , Bradshaw, H. B. , Selley, D. E. , & Mackie, K. (2014b). Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice. Journal of Neuroscience, 34, 5152–5163. 10.1523/JNEUROSCI.3445-12.2014 PubMed DOI PMC

Nealon, C. M. , Henderson‐Redmond, A. N. , Hale, D. E. , & Morgan, D. J. (2019). Tolerance to WIN55,212‐2 is delayed in desensitization‐resistant S426A/S430A mice. Neuropharmacology, 148, 151–159. 10.1016/j.neuropharm.2018.12.026 PubMed DOI PMC

Nguyen, P. T. , Schmid, C. L. , Raehal, K. M. , Selley, D. E. , Bohn, L. M. , & Sim‐Selley, L. J. (2012). β‐Arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region‐dependent manner. Biological Psychiatry, 71, 714–724. 10.1016/j.biopsych.2011.11.027 PubMed DOI PMC

Niehaus, J. L. , Liu, Y. , Wallis, K. T. , Egertova, M. , Bhartur, S. G. , Mukhopadhyay, S. , Shi, S. , He, H. , Selley, D. E. , Howlett, A. C. , Elphick, M. R. , & Lewis, D. L. (2007). CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. Molecular Pharmacology, 72, 1557–1566. 10.1124/mol.107.039263 PubMed DOI

Percie du Sert, N. , Hurst, V. , Ahluwalia, A. , Alam, S. , Avey, M. T. , Baker, M. , Browne, W. J. , Clark, A. , Cuthill, I. C. , Dirnagl, U. , Emerson, M. , Garner, P. , Holgate, S. T. , Howells, D. W. , Karp, N. A. , Lazic, S. E. , Lidster, K. , MacCallum, C. J. , Macleod, M. , … Würbel, H. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biology, 18(7), e3000410. 10.1371/journal.pbio.3000410 PubMed DOI PMC

Pertwee, R. G. (1972). The ring test: A quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice. British Journal of Pharmacology, 46, 753–763. 10.1111/j.1476-5381.1972.tb06900.x PubMed DOI PMC

Porsolt, R. D. , Le Pichon, M. , & Jalfre, M. (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature, 266, 730–732. 10.1038/266730a0 PubMed DOI

Rahn, E. J. , Thakur, G. A. , Wood, J. A. , Zvonok, A. M. , Makriyannis, A. , & Hohmann, A. G. (2011). Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side‐effects. Pharmacology, Biochemistry, and Behavior, 98, 493–502. 10.1016/j.pbb.2011.02.024 PubMed DOI PMC

Ramabadran, K. , Bansinath, M. , Turndorf, H. , & Puig, M. M. (1989). Tail immersion test for the evaluation of a nociceptive reaction in mice—Methodological considerations. Journal of Pharmacological Methods, 21, 21–31. 10.1016/0160-5402(89)90019-3 PubMed DOI

Reich, C. G. , Taylor, M. E. , & McCarthy, M. M. (2009). Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behavioural Brain Research, 203, 264–269. 10.1016/j.bbr.2009.05.013 PubMed DOI PMC

Rey, A. A. , Purrio, M. , Viveros, M. P. , & Lutz, B. (2012). Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology, 37, 2624–2634. 10.1038/npp.2012.123 PubMed DOI PMC

Richardson, J. D. , Aanonsen, L. , & Hargreaves, K. M. (1998). Hypoactivity of the spinal cannabinoid system results in NMDA‐dependent hyperalgesia. Journal of Neuroscience, 18, 451–457. 10.1523/JNEUROSCI.18-01-00451.1998 PubMed DOI PMC

Rinaldi‐Carmona, M. , Barth, F. , Heaulme, M. , Shire, D. , Calandra, B. , Congy, C. , Martinez, S. , Maruani, J. , Néliat, G. , Caput, D. , Ferrara, P. , Soubrié, P. , Brelière, J. C. , & Fur, G. L. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters, 350, 240–244. 10.1016/0014-5793(94)00773-X PubMed DOI

Rinaldi‐Carmona, M. , Le Duigou, A. , Oustric, D. , Barth, F. , Bouaboula, M. , Carayon, P. , Casellas, P. , & Le Fur, G. (1998). Modulation of CB1 cannabinoid receptor functions after a long‐term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system. Journal of Pharmacology and Experimental Therapeutics, 287, 1038–1047. PubMed

Robledo, P. , Berrendero, F. , Ozaita, A. , & Maldonado, R. (2008). Advances in the field of cannabinoid–opioid cross‐talk. Addiction Biology, 13, 213–224. 10.1111/j.1369-1600.2008.00107.x PubMed DOI

Rozenfeld, R. , & Devi, L. A. (2008). Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP‐3. FASEB Journal, 22, 2311–2322. 10.1096/fj.07-102731 PubMed DOI PMC

Shonesy, B. C. , Bluett, R. J. , Ramikie, T. S. , Baldi, R. , Hermanson, D. J. , Kingsley, P. J. , Marnett, L. J. , Winder, D. G. , Colbran, R. J. , & Patel, S. (2014). Genetic disruption of 2‐arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. Cell Reports, 9, 1644–1653. 10.1016/j.celrep.2014.11.001 PubMed DOI PMC

Simon, A. C. , Loverdo, C. , Gaffuri, A. L. , Urbanski, M. , Ladarre, D. , Carrel, D. , Rivals, I. , Leterrier, C. , Benichou, O. , Dournaud, P. , Szabo, B. , Voituriez, R. , & Lenkei, Z. (2013). Activation‐dependent plasticity of polarized GPCR distribution on the neuronal surface. Journal of Molecular Cell Biology, 5, 250–265. 10.1093/jmcb/mjt014 PubMed DOI

Stiedl, O. , Radulovic, J. , Lohmann, R. , Birkenfeld, K. , Palve, M. , Kammermeier, J. , Sananbenesi, F. , & Spiess, J. (1999). Strain and substrain differences in context‐ and tone‐dependent fear conditioning of inbred mice. Behavioural Brain Research, 104, 1–12. 10.1016/S0166-4328(99)00047-9 PubMed DOI

Team RC . (2020). R: A language and environment for statistical computing. Vienna, Austria. URL: R Foundation for Statistical Computing. https://www.R-project.org/

Trevaskis, J. , Walder, K. , Foletta, V. , Kerr‐Bayles, L. , McMillan, J. , Cooper, A. , Lee, S. , Bolton, K. , Prior, M. , Fahey, R. , Whitecross, K. , Morton, G. J. , Schwartz, M. W. , & Collier, G. R. (2005). Src homology 3‐domain growth factor receptor‐bound 2‐like (endophilin) interacting protein 1, a novel neuronal protein that regulates energy balance. Endocrinology, 146, 3757–3764. 10.1210/en.2005-0282 PubMed DOI

Uezu, A. , Horiuchi, A. , Kanda, K. , Kikuchi, N. , Umeda, K. , Tsujita, K. , Suetsugu, S. , Araki, N. , Yamamoto, H. , Takenawa, T. , & Nakanishi, H. (2007). SGIP1α is an endocytic protein that directly interacts with phospholipids and Eps15. Journal of Biological Chemistry, 282, 26481–26489. 10.1074/jbc.M703815200 PubMed DOI

Velasco, E. R. , Florido, A. , Milad, M. R. , & Andero, R. (2019). Sex differences in fear extinction. Neuroscience and Biobehavioral Reviews, 103, 81–108. 10.1016/j.neubiorev.2019.05.020 PubMed DOI PMC

Wilhelm, B. G. , Mandad, S. , Truckenbrodt, S. , Krohnert, K. , Schafer, C. , Rammner, B. , Koo, S. J. , Claßen, G. A. , Krauss, M. , Haucke, V. , Urlaub, H. , & Rizzoli, S. O. (2014). Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science, 344, 1023–1028. 10.1126/science.1252884 PubMed DOI

Woodhams, S. G. , Chapman, V. , Finn, D. P. , Hohmann, A. G. , & Neugebauer, V. (2017). The cannabinoid system and pain. Neuropharmacology, 124, 105–120. 10.1016/j.neuropharm.2017.06.015 PubMed DOI PMC

Wu, D. F. , Yang, L. Q. , Goschke, A. , Stumm, R. , Brandenburg, L. O. , Liang, Y. J. , Höllt, V. , & Koch, T. (2008). Role of receptor internalization in the agonist‐induced desensitization of cannabinoid type 1 receptors. Journal of Neurochemistry, 104, 1132–1143. 10.1111/j.1471-4159.2007.05063.x PubMed DOI

Yeomans, J. S. , & Frankland, P. W. (1995). The acoustic startle reflex: Neurons and connections. Brain Research. Brain Research Reviews, 21, 301–314. 10.1016/0165-0173(96)00004-5 PubMed DOI

Zimmer, A. , Zimmer, A. M. , Hohmann, A. G. , Herkenham, M. , & Bonner, T. I. (1999). Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America, 96, 5780–5785. 10.1073/pnas.96.10.5780 PubMed DOI PMC

Hexahydrocannabinol (HHC) and Δ9-tetrahydrocannabinol (Δ9-THC) driven activation of cannabinoid receptor 1 results in biased intracellular signaling

SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function

A collection of cannabinoid-related negative findings from autaptic hippocampal neurons

SGIP1 modulates kinetics and interactions of the cannabinoid receptor 1 and G protein-coupled receptor kinase 3 signalosome